Citadel Advisors - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 15 filers reported holding CLEVELAND BIOLABS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q1 2021$192,000
+405.3%
36,626
+228.3%
0.00%
Q4 2020$38,000
+90.0%
11,155
-7.1%
0.00%
Q1 2020$20,000
-31.0%
12,009
-57.8%
0.00%
Q3 2019$29,000
-23.7%
28,435
+84.8%
0.00%
Q2 2018$38,000
-7.3%
15,389
+14.0%
0.00%
Q1 2018$41,000
+17.1%
13,501
+34.6%
0.00%
Q3 2017$35,000
-23.9%
10,032
-36.2%
0.00%
Q2 2017$46,000
-11.5%
15,718
-47.4%
0.00%
Q3 2016$52,00029,8990.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q4 2019
NameSharesValueWeighting ↓
THOMPSON DAVIS & CO., INC. 1,800$8,0000.01%
VANGUARD GROUP INC 4,644,077$162,991,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 38,888$158,0000.00%
Winfield Associates, Inc. 786$3,0000.00%
Virtu KCG Holdings LLC 11,022$48,0000.00%
UBS Group AG 182$00.00%
BLACKROCK ADVISORS LLC 2,800$12,0000.00%
US BANCORP \DE\ 100$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 37$00.00%
BANK OF AMERICA CORP /DE/ 150$1,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders